# 21 C.F.R. § 310.502 (2026): Certain drugs accorded new drug status through rulemaking procedures

> Federal · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_502

## Section

- **Citation:** 21 C.F.R. § 310.502 (2026)
- **Heading:** Certain drugs accorded new drug status through rulemaking procedures
- **Jurisdiction:** Federal
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Title 21 CFR: Food and Drugs / Chapter I / Part 310 / Subpart E / § 310.502: § 310.502   Certain drugs accorded new drug status through rulemaking procedures.

## Text

(a) The drugs listed in this paragraph (a) have been determined by rulemaking procedures to be new drugs within the meaning of section 201(p) of the Federal Food, Drug, and Cosmetic Act. An approved new drug application under section 505 of the Federal Food, Drug, and Cosmetic Act and part 314 of this chapter is required for marketing the following drugs: (1) Aerosol drug products for human use containing 1,1,1-trichloroethane. (2) Aerosol drug products containing zirconium. (3) Amphetamines (amphetamine, dextroamphetamine, and their salts, and levamfetamine and its salts) for human use. (4) Camphorated oil drug products. (5) Certain halogenated salicylanilides (tribromsalan (TBS, 3,4′,5-tribromosalicylanilide), dibromsalan (DBS, 4′, 5-dibromosalicylanilide), metabromsalan (MBS, 3, 5-dibromosalicylanilide), and 3,3′, 4,5′-tetrachlorosalicylanilide (TC-SA)) as an ingredient in drug products. (6) Chloroform used as an ingredient (active or inactive) in drug products. (7) Cobalt preparations intended for use by man. (8) Intrauterine devices for human use for the purpose of contraception that incorporate heavy metals, drugs, or other active substances. (9) Oral prenatal drugs containing fluorides intended for human use. (10) Parenteral drug products in plastic containers. (11) [Reserved] (12) Sweet spirits of nitre drug products. (13) Thorium dioxide for drug use. (14) Timed release dosage forms. (15) Vinyl chloride as an ingredient, including propellant, in aerosol drug products. (b) [Reserved] [62 FR 12084, Mar. 14, 1997, as amended at 64 FR 401, Jan. 5, 1999; 84 FR 68334, Dec. 16, 2019]

## Nearby sections

- [21 C.F.R. § 310.501 (2026) § 310.501   Patient package inserts for oral contraceptives.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_501.md)
- [21 C.F.R. § 310.502 (2026) § 310.502   Certain drugs accorded new drug status through rulemaking procedures.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_502.md)
- [21 C.F.R. § 310.503 (2026) § 310.503   Requirements regarding certain radioactive drugs.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_503.md)
- [21 C.F.R. § 310.509 (2026) § 310.509   Parenteral drug products in plastic containers.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_509.md)
- [21 C.F.R. § 310.515 (2026) § 310.515   Patient package inserts for estrogens.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_515.md)
- [21 C.F.R. § 310.517 (2026) § 310.517   Labeling for oral hypoglycemic drugs of the sulfonylurea class.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_517.md)
- [21 C.F.R. § 310.518 (2026) § 310.518   Drug products containing iron or iron salts.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_518.md)
- [21 C.F.R. § 310.519 (2026) § 310.519   Drug products marketed as over-the-counter (OTC) daytime sedatives.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_519.md)
- [21 C.F.R. § 310.527 (2026) § 310.527   Drug products containing active ingredients offered over-the-counter (OTC) for external use as hair growers or for hair loss prevention.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_527.md)
- [21 C.F.R. § 310.528 (2026) § 310.528   Drug products containing active ingredients offered over-the-counter (OTC) for use as an aphrodisiac.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_528.md)
- [21 C.F.R. § 310.529 (2026) § 310.529   Drug products containing active ingredients offered over-the-counter (OTC) for oral use as insect repellents.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_529.md)
- [21 C.F.R. § 310.530 (2026) § 310.530   Topically applied hormone-containing drug products for over-the-counter (OTC) human use.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_530.md)
- [21 C.F.R. § 310.531 (2026) § 310.531   Drug products containing active ingredients offered over-the-counter (OTC) for the treatment of boils.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_531.md)
- [21 C.F.R. § 310.532 (2026) § 310.532   Drug products containing active ingredients offered over-the-counter (OTC) to relieve the symptoms of benign prostatic hypertrophy.](https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_532.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/CFR_T21_P310_S310_502. Check the current official text before relying on it. Not legal advice.